Cutler Group’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-200
Closed -$1K 5931
2021
Q4
$1K Buy
+200
New +$10.1K ﹤0.01% 5118
2020
Q3
Sell
-3,600
Closed -$5K 5178
2020
Q2
$5K Sell
3,600
-6,800
-65% -$192K ﹤0.01% 3334
2020
Q1
$2K Buy
10,400
+8,400
+420% +$242K ﹤0.01% 3545
2019
Q4
$8K Buy
+2,000
New +$55.9K ﹤0.01% 2776
2019
Q3
Sell
-5,600
Closed -$3K 4603
2019
Q2
$3K Buy
5,600
+2,000
+56% +$49.6K ﹤0.01% 3412
2019
Q1
$3K Buy
+3,600
New +$90.8K ﹤0.01% 3243
2018
Q4
Sell
-400
Closed -$2K 4496
2018
Q3
$2K Buy
+400
New +$10.5K ﹤0.01% 3559
2018
Q1
Sell
-2,800
Closed -$5K 5098
2017
Q4
$5K Sell
2,800
-800
-22% -$17.4K ﹤0.01% 3654
2017
Q3
$5K Buy
+3,600
New +$73.8K ﹤0.01% 4422

Other funds holding RXL

Cutler Group's RXL Position: Q1 2022 in Review

Cutler Group sold out of ProShares Ultra Health Care (RXL) in Q1 2022, closing a stake of 200 shares — an estimated $11K sold.

Cutler Group first reported a position in RXL in Q3 2016 and held it in 11 quarters. The position peaked at $144K in Q1 2020. 22 funds tracked by Wall St. Rank hold RXL as of Q1 2022.

  • Cutler Group reported no remaining ProShares Ultra Health Care position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 200 ProShares Ultra Health Care shares in Q1 2022, an estimated $11K.
  • Cutler Group first reported a position in ProShares Ultra Health Care in Q3 2016 and held it in 11 quarters.
  • Cutler Group's ProShares Ultra Health Care position peaked at $144K in Q1 2020.
  • 22 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.